KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/11/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization403,538 mln
Float68.73 mln
Earnings Date07/23/2025
EPS
85.00
Exceptional
P / E
46.71
High premium
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.38
Manipulation likely
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.24
Very low leverage
Business Description
Founded in 1960 and based in Seoul, Bukwang Pharmaceutical is a South Korean drug maker that sells a wide range of prescription medicines, over-the-counter products, and everyday health items such as vitamins, oral care goods, and dietary supplements, both at home and abroad. The company serves patients across many medical fields, from heart disease and cancer to digestive and mental health conditions. It is also advancing a pipeline of new treatments targeting schizophrenia, Parkinson's disease, prostate cancer, and other serious illnesses.